Latest filing published 23 May 2025 for Tandem Diabetes Care INC, €80k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Christopher J. Twomey in Tandem Diabetes Care Inc, where the filings describe the role as board member. We count 10 filings; the first trade dates from 19 May 2021 and the latest from 22 May 2025.
The open-market record consists of 3 sales worth €860k, with no purchase. The rest of the record consists of 7 option exercises.
The record was last updated on 23 May 2025 with an option exercise (€80k) in Tandem Diabetes Care Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations